Lectenz Bio at 2022 Common Fund GlycoScience Program

Related Posts

• 
  Lectenz Bio completes NIH I-Corps program

  Lectenz Bio completed the Spring 2019 SBIR NIH I-Corps cohort in Bethesda Maryland! During the…

• 
  Lectenz Bio accepted to NIH I-Corps program

  Lectenz Bio has been accepted to the National Institute of Health (NIH) I-Corps program for…

• 
  Lectenz Bio participates in NIH Commercialization Accelerator Program

  The Lectenz Bio participated in the 2015-2016 Advanced Commercialization Track in the NIH Commercialization Accelerator…